The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGfinity Regulatory News (GFIN)

Share Price Information for Gfinity (GFIN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.035
Bid: 0.03
Ask: 0.04
Change: 0.00 (0.00%)
Spread: 0.01 (33.333%)
Open: 0.035
High: 0.035
Low: 0.035
Prev. Close: 0.035
GFIN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Gfinity plc

19 Oct 2020 14:54

RNS Number : 5152C
Gfinity PLC
19 October 2020
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

HENRY JAMES REDKNAPP

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

GFINITY PLC

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

12/10/20

 

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A:

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:0.1p Ordinary

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

(2) Cash-settled derivatives:

 

8,000,000

1.04

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

TOTAL:

8,000,000

1.04

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

NIL

Details, including nature of the rights concerned and relevant percentages:

NIL

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

0.1p Ordinary

Spreadbet

Reducing a long position

1,000,000

GBX 4.418925

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

19/10/20

Contact name:

Beavis Morgan LLP

Telephone number*:

020 7417 0417

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETFFEFDUESSEIS
Date   Source Headline
28th Jul 20177:00 amRNSBBC Three to broadcast Gfinity's Elite Series
24th Jul 20177:00 amRNSAcquisition of CEVO, Inc
21st Jul 20177:00 amRNSEleven Sports to broadcast Elite Series
7th Jul 20177:00 amRNSAppointment of Chief Commercial Officer
6th Jul 20177:00 amRNSElite Series Update
29th Jun 20175:14 pmRNSExclusive Halo Event Partnership with Microsoft
13th Jun 20173:50 pmRNSStrategic Partnership with IKON Media & Ent.
2nd Jun 20177:00 amRNSExclusive Partnership: 24 Hours of Le Mans
31st May 20175:00 pmRNSTotal Voting Rights
26th May 20178:27 amRNSEpsilon eSports to compete in the Elite Series
24th May 20177:00 amRNSTeam Method to compete in the Elite Series
19th May 20177:00 amRNSElite Series: Official Dates and Further Details
18th May 20177:00 amRNSTeam Endpoint to compete in the Elite Series
15th May 201710:22 amRNSSenior Management Appointments
12th May 20179:21 amRNSPlacing of shares to raise £6.25 million
13th Apr 20177:00 amRNSExclusive Partnership with Microsoft
30th Mar 201712:00 pmRNSTeam EnVyUs to compete in the Elite Series
29th Mar 201712:14 pmRNSFirst four Gfinity Elite Series Teams
28th Mar 20177:00 amRNSHalf-year Report
27th Mar 201712:30 pmRNSRocket League to form part of Elite Series
23rd Mar 20177:00 amRNSOMEN by HP: first official partner of Elite Series
8th Mar 201712:00 pmRNSStreet Fighter V to form part of Elite Series
6th Mar 201712:47 pmRNSLaunch of Gfinity Challenger Series
30th Jan 20177:00 amRNSStrategic Partnership with MediaCom
5th Jan 20177:00 amRNSAppointment as partner for CoD World League Events
20th Dec 201611:01 amRNSResult of AGM
12th Dec 20167:00 amRNSAppointment as events partner for Halo tournament
24th Nov 20165:07 pmRNSNotice of AGM
17th Nov 20167:00 amRNSLaunch of the Gfinity Elite Series
8th Nov 20167:00 amRNSFinal Results
30th Aug 20167:00 amRNSSponsorship agreement
3rd Aug 20164:00 pmRNSHolding(s) in Company
1st Aug 20167:00 amRNSGfinity to host Xbox Gears of War 4 eSports events
21st Jul 20162:10 pmRNSGrant of Share Options
21st Jul 20162:07 pmRNSHolding(s) in Company
21st Jul 20169:19 amRNSHolding(s) in Company
20th Jul 201610:33 amRNSResult of General Meeting and Total Voting Rights
4th Jul 201610:29 amRNSProposed placing to raise £3.7m
8th Jun 20167:00 amRNSPartnership Agreement with Futhead.com
7th Jun 20167:00 amRNSSponsorship Agreement with Gillette
2nd Jun 20169:45 amRNSChange of nominated adviser and broker
31st May 20167:00 amRNSBoard Changes
21st Apr 20167:00 amRNSGfinity launches exclusive Xbox One App
22nd Mar 20167:00 amRNSInterim Results
18th Feb 20167:00 amRNSGfinity to Host Vainglory Championship Finals
11th Jan 20167:00 amRNSGfinity to host European FIFA 16 series
14th Dec 20153:29 pmRNSResult of AGM
3rd Dec 201512:27 pmRNSGrant of Share Options
23rd Nov 20157:00 amRNSGfinity Selected by Microsoft
20th Nov 20153:38 pmRNSNotice of AGM and Posting of Annual Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.